A new drug for the treatment of hereditary transthyretin amyloid polyneuropathy: eplontersen

ZHU Haibin; WANG Yue; LIAO Xiaolan; WU Tingting; YU Zicheng

doi:10.13683/j.wph.2025.07.015

World Clinical Drugs, Volume. 46, Issue 7, 715(2025)

A new drug for the treatment of hereditary transthyretin amyloid polyneuropathy: eplontersen

ZHU Haibin¹, WANG Yue², LIAO Xiaolan¹, WU Tingting¹, and YU Zicheng¹

Author Affiliations

¹Department of Pharmacy, Yangpu Hospital, School of Medicine Tongji University, Shanghai 200090, China

²Department of Pharmacy, Beijing Hospital/National Center of Gerontology, Institute of Geriatric Medicine/Chinese Academy of Medical Sciences, Beijing 100730, China

show less

Abstract Get PDF(in Chinese)

Figures & Tables(0)

Tools

Get Citation

Copy Citation Text

ZHU Haibin, WANG Yue, LIAO Xiaolan, WU Tingting, YU Zicheng. A new drug for the treatment of hereditary transthyretin amyloid polyneuropathy: eplontersen[J]. World Clinical Drugs, 2025, 46(7): 715

Download Citation

EndNote(RIS)BibTex Plain Text

Set citation alerts for article

Save article for my favorites

Paper Information

Category:

Received: Dec. 28, 2024

Accepted: Aug. 26, 2025

Published Online: Aug. 26, 2025

The Author Email:

DOI:10.13683/j.wph.2025.07.015

Topics